A novel therapeutic option in pemphigus vulgaris: humanized monoclonal anti-CD25 antibody

Br J Dermatol. 2004 Jun;150(6):1220-2. doi: 10.1111/j.1365-2133.2004.05977.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Azathioprine / therapeutic use
  • Daclizumab
  • Drug Therapy, Combination
  • Female
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Immunosuppressive Agents / therapeutic use*
  • Middle Aged
  • Pemphigus / drug therapy*
  • Pemphigus / immunology
  • Prednisolone / therapeutic use
  • Receptors, Interleukin-2 / immunology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Interleukin-2
  • Prednisolone
  • Daclizumab
  • Azathioprine